E
Adaptimmune Therapeutics plc ADAP
$0.3239 $0.01896.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.04
Price History ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 29.56%
30-Day Total Return -44.11%
60-Day Total Return -50.17%
90-Day Total Return -51.27%
Year to Date Total Return -48.05%
1-Year Total Return -76.53%
2-Year Total Return -69.44%
3-Year Total Return -85.48%
5-Year Total Return -87.68%
52-Week High % Change -79.39%
52-Week Low % Change 56.33%
Price ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $1.48
52-Week Low Price $0.20
52-Week Low Price (Date) Apr 01, 2025
52-Week High Price (Date) Jul 30, 2024
Valuation ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 78.46M
Enterprise Value 1.06M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -2.03
Earnings Per Share Growth -35.70%
Price/Earnings To Growth --
Price/Sales (TTM) 0.07
Price/Book (Q) 1.10
Enterprise Value/Revenue (TTM) 0.01
Price $0.32
Enterprise Value/EBITDA (TTM) -0.02
Enterprise Value/EBIT -0.02
Market Cap Category Micro Cap
Dividends and Shares ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 42.65M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 44 12 3543 0000
Address --
Website www.adaptimmune.com
Country United Kingdom
Year Founded 2008
Profitability ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -33.56%
Profit Margin -39.77%
Management Effectiveness ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -14.13%
Return on Equity --
Income Statement ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 178.03M
Total Revenue (TTM) 178.03M
Revenue Per Share $4.17
Gross Profit (TTM) 28.90M
EBITDA (TTM) -48.53M
EBIT (TTM) -59.76M
Net Income (TTM) -70.81M
Net Income Avl. to Common (TTM) -70.81M
Total Revenue Growth (Q YOY) 1,294.81%
Earnings Growth (Q YOY) -54.88%
EPS Diluted (TTM) -2.03
EPS Diluted Growth (Q YOY) -46.45%
Balance Sheet ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 151.61M
Cash Per Share (Q) $3.55
Total Current Assets (Q) 188.17M
Total Preferred Equity (Q) --
Total Equity (Q) 11.85M
Current Ratio (Q) 2.916
Book Value Per Share (Q) $0.28
Total Assets (Q) 245.96M
Total Current Liabilities (Q) 64.53M
Total Debt (Q) 74.21M
Total Liabilities (Q) 234.11M
Total Common Equity (Q) 11.85M
Cash Flow ADAP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -58.95M
Cash from Financing (TTM) 78.75M
Net Change in Cash (TTM) -53.81M
Levered Free Cash Flow (TTM) -2.42M
Cash from Operations (TTM) -73.21M
Weiss Ratings